Annual CFF
$27.04 M
+$18.06 M+200.89%
31 December 2023
Summary:
IN8bio annual cash flow from financing activities is currently $27.04 million, with the most recent change of +$18.06 million (+200.89%) on 31 December 2023. During the last 3 years, it has risen by +$2.53 million (+10.31%). INAB annual CFF is now -17.94% below its all-time high of $32.95 million, reached on 31 December 2021.INAB Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$105.00 K
-$3.48 M-103.11%
30 September 2024
Summary:
IN8bio quarterly cash flow from financing activities is currently -$105.00 thousand, with the most recent change of -$3.48 million (-103.11%) on 30 September 2024. Over the past year, it has dropped by -$1.76 million (-106.36%). INAB quarterly CFF is now -100.30% below its all-time high of $35.19 million, reached on 30 September 2021.INAB Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$16.35 M
-$1.76 M-9.70%
30 September 2024
Summary:
IN8bio TTM cash flow from financing activities is currently $16.35 million, with the most recent change of -$1.76 million (-9.70%) on 30 September 2024. Over the past year, it has increased by +$2.91 million (+21.65%). INAB TTM CFF is now -51.65% below its all-time high of $33.81 million, reached on 30 June 2022.INAB TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INAB Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +200.9% | -106.4% | +21.6% |
| 3 y3 years | +10.3% | -100.3% | -50.8% |
| 5 y5 years | +218.1% | - | - |
INAB Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -17.9% | +200.9% | -100.3% | +91.3% | -51.6% | +103.6% |
| 5 y | 5 years | -17.9% | >+9999.0% | -100.3% | +91.3% | -51.6% | +187.8% |
| alltime | all time | -17.9% | >+9999.0% | -100.3% | +91.3% | -51.6% | +187.8% |
IN8bio Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$105.00 K(-103.1%) | $16.35 M(-9.7%) |
| June 2024 | - | $3.38 M(-1319.9%) | $18.11 M(-30.9%) |
| Mar 2024 | - | -$277.00 K(-102.1%) | $26.22 M(-3.0%) |
| Dec 2023 | $27.04 M(+200.9%) | $13.35 M(+708.2%) | $27.04 M(+101.2%) |
| Sept 2023 | - | $1.65 M(-85.6%) | $13.44 M(-36.6%) |
| June 2023 | - | $11.49 M(+2001.1%) | $21.20 M(+120.0%) |
| Mar 2023 | - | $547.00 K(-316.2%) | $9.64 M(+7.2%) |
| Dec 2022 | $8.99 M | -$253.00 K(-102.7%) | $8.99 M(+11.9%) |
| Sept 2022 | - | $9.41 M(<-9900.0%) | $8.03 M(-76.3%) |
| June 2022 | - | -$67.00 K(-34.3%) | $33.81 M(+1.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$102.00 K(-91.6%) | $33.29 M(+1.0%) |
| Dec 2021 | $32.95 M(+34.4%) | -$1.21 M(-103.4%) | $32.95 M(-0.8%) |
| Sept 2021 | - | $35.19 M(-6044.9%) | $33.22 M(+88.4%) |
| June 2021 | - | -$592.00 K(+36.1%) | $17.64 M(-4.2%) |
| Mar 2021 | - | -$435.00 K(-54.2%) | $18.40 M(-24.9%) |
| Dec 2020 | $24.52 M(>+9900.0%) | -$949.00 K(-104.8%) | $24.52 M(-3.7%) |
| Sept 2020 | - | $19.61 M(>+9900.0%) | $25.47 M(+335.0%) |
| June 2020 | - | $174.00 K(-96.9%) | $5.85 M(+3.1%) |
| Mar 2020 | - | $5.68 M | $5.68 M |
| Dec 2019 | $65.00 K(-99.2%) | - | - |
| Dec 2018 | $8.50 M | - | - |
FAQ
- What is IN8bio annual cash flow from financing activities?
- What is the all time high annual CFF for IN8bio?
- What is IN8bio annual CFF year-on-year change?
- What is IN8bio quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for IN8bio?
- What is IN8bio quarterly CFF year-on-year change?
- What is IN8bio TTM cash flow from financing activities?
- What is the all time high TTM CFF for IN8bio?
- What is IN8bio TTM CFF year-on-year change?
What is IN8bio annual cash flow from financing activities?
The current annual CFF of INAB is $27.04 M
What is the all time high annual CFF for IN8bio?
IN8bio all-time high annual cash flow from financing activities is $32.95 M
What is IN8bio annual CFF year-on-year change?
Over the past year, INAB annual cash flow from financing activities has changed by +$18.06 M (+200.89%)
What is IN8bio quarterly cash flow from financing activities?
The current quarterly CFF of INAB is -$105.00 K
What is the all time high quarterly CFF for IN8bio?
IN8bio all-time high quarterly cash flow from financing activities is $35.19 M
What is IN8bio quarterly CFF year-on-year change?
Over the past year, INAB quarterly cash flow from financing activities has changed by -$1.76 M (-106.36%)
What is IN8bio TTM cash flow from financing activities?
The current TTM CFF of INAB is $16.35 M
What is the all time high TTM CFF for IN8bio?
IN8bio all-time high TTM cash flow from financing activities is $33.81 M
What is IN8bio TTM CFF year-on-year change?
Over the past year, INAB TTM cash flow from financing activities has changed by +$2.91 M (+21.65%)